• contact us
  • |
  • home
  • |
  • rho canada
  • |
  • rho fund investors
  • |
  • twitter   follow us
search
rho Logo
    • Rho Ventures Investing Approach
    • Rho Values
    • Fast Facts
    • Overview
    • Partners
    • Principals
    • Associates
    • Chief Financial Officer
    • General Counsel
    • Key Successes
    • Investments
    • Case Studies
    • Energy Technology
    • Healthcare
    • IT & Communications
    • New Media
    • Jobs @ Rho Companies
    • Portfolio News
    • Rho Ventures News
    • Archived News
Portfolio > Healthcare > Historical > MedImmune

MedImmune

Sector:
Healthcare

Location:
Gaithersburg, MD

Year Funded:
1991

Status:
IPO/Acquired by
AstraZeneca

Website:
www.medimmune.com


Summary:
MedImmune is the worldwide biologics business for AstraZeneca PLC.

 

Key Successes
Investments
Case Studies
Energy Technology
Healthcare
Current
Historical
3DP
Archemix
Dendreon
Dyax
Gloucester Pharmaceuticals
GynoPharma
Genetic Therapy
Health Allies
Human Genome Sciences
LeukoSite
MedImmune
Memory Pharmaceuticals
MPV
NitroMed
Osteotech
Pharmavene
Principia
Senomyx
STC
Tercica
TolerRx
Upstate
Vanda
Verathon
Vicuron
Virus Research
IT & Communications
New Media
Jobs @ Rho Companies
  • Copyright © 2010 Rho Ventures. All rights reserved